发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 117 |
| Italy | 103 |
| England | 42 |
| Spain | 31 |
| CHINA MAINLAND | 28 |
| France | 27 |
| GERMANY (FED REP GER) | 21 |
| Netherlands | 20 |
| Canada | 16 |
| Japan | 16 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERC... | 12 |
| HARVARD UNIVERSITY | 11 |
| UNIVERSITY OF BOLOGNA | 11 |
| CATHOLIC UNIVERSITY OF THE SACRED HEART | 9 |
| CIBER - CENTRO DE INVESTIGACION BIOMEDICA EN R... | 9 |
| UNIVERSITY OF LONDON | 9 |
| UNIVERSITY OF MILAN | 9 |
| UNIVERSITY OF ROME TOR VERGATA | 9 |
| UNIVERSITA DELLA CAMPANIA VANVITELLI | 8 |
| UNIVERSITY OF FLORENCE | 8 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| An update on the clinical consequences of polypharmacy i... | 48 |
| An update on the safety of SGLT2 inhibitors | 28 |
| Safety and tolerability of available urate-lowering drug... | 20 |
| Risk of opportunistic infections in patients treated wit... | 17 |
| The safety of gliptins : updated data in 2018 | 17 |
| Liver safety parameters of ulipristal acetate for the tr... | 16 |
| Anakinra for the treatment of rheumatoid arthritis: a sa... | 16 |
| Drug-drug interactions as a result of co-administering D... | 15 |
| Metabolic complications affecting adipose tissue, lipid ... | 15 |
| Update on BRAF and MEK inhibition for treatment of melan... | 14 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| EXPERT OPIN DRUG SAF | 76 |
| FRONT PHARMACOL | 60 |
| INT J MOL SCI | 56 |
| PLOS ONE | 41 |
| SCI REP-UK | 33 |
| DRUG SAFETY | 31 |
| EXPERT OPIN PHARMACO | 29 |
| MEDICINE | 27 |
| BMJ OPEN | 25 |
| EXPERT OPIN DRUG MET | 22 |